Viewing Study NCT00064727

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 5:08 AM

Ignite Modification Date: 2025-12-26 @ 4:12 AM

Study NCT ID: NCT00064727

Status: COMPLETED

Last Update Posted: 2017-07-02

First Post: 2003-07-10

Is NOT Gene Therapy: False

Has Adverse Events: False

Brief Title: Rosiglitazone to Treat Patients With Heart Failure and Glucose Intolerance or Type II Diabetes

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module